Company profile

Adalyon company profile

Adalyon provides AI solutions to pharma R&D and CROs as well as clinicians and health providers to deploy next-gen speech biomarkers into clinical research and practice. Using advanced NLP, LLMs, and Ayda Insights - Adalyon's behavioural analytics platform - Adalyon extracts novel speech-based digital biomarkers to: - Detect treatment effects earlier across therapeutic areas in digital trials. - Capture meaningful quality-of-life outcomes in chronic and acute conditions. - Bring treatments to market faster across neurological, psychiatric, and cognitive health. - Enable real-time, data-driven health monitoring through apps and platforms. Adalyon's AI platform includes an API for compiling custom speech biomarkers,..... For more information, log in to dureach.com to view the full company profile.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
00001-00010 employees
Founded
2021-01-01

Headquarters

Headquarters
Espoo, Uusimaa, Finland
Postal code
02150
Country code
FI
Continent
Europe

Capital profile

Funding and company signals

Founders
1
Articles
4

Founders and investors

Founders

Katarina Cantell

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.